NeurologyLonza AG enters R&D collaboration with NeuroSense Therapeutics LtdLatest NewsALS specialist NeuroSense Therapeutics Ltd announces it will be collaborating with Swiss Lonza AG to identify exosome-based biomarkers to advance theranostics in neurodegeneration. Read more 10 April 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/Neurosense-pipeline.png 966 2120 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-04-10 09:31:422024-06-13 13:41:48Lonza AG enters R&D collaboration with NeuroSense Therapeutics Ltd